Investor List:

Top Medical Devices Series B Investors in LatAm (Latin America) (13)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Medical Devices investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Juergen Wassmann, General Partner at Yaya Capital
Juergen Wassmann
Yaya Capital·General Partner
Sweet spot: $2.5M
Range: $100K - $5.0M
Investors in Brazil
Investors in Medical Devices (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in Web3/Blockchain (Series B), Investors in Web3/Crypto (Series B), Investors in Cloud Infrastructure (Series B), Investors in Consumer Health (Series B), Investors in Consumer Health (Series A), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Digital Health (Series B), Investors in Consumer Health (Seed), Investors in Cloud Infrastructure (Seed), Investors in Health IT (Seed), Investors in Cloud Infrastructure (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Web3/Crypto (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in Web3/Crypto (Seed), Investors in Web3/Blockchain (Series A), Investors in Digital Health (Seed), Investors in Web3/Blockchain (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Medical Devices (Series B), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in Consumer Health (Series B), Investors in Web3/Blockchain (Series B), Investors in BioTech (Series B), Investors in LatAm (Latin America) (Other Lists), Investors in Cloud Infrastructure (Series B), Investors in Raleigh-Durham / Southeast US (Other Lists), Investors in Digital Health (Series B), Investors in Web3/Crypto (Series B), Investors in Health IT (Series B), Investors in Consumer Health (Series A), Investors in Health & Hospital Services (Series B), Investors in Web3/Blockchain (Seed), Investors in Web3/Blockchain (Series A), Investors in Cloud Infrastructure (Seed), Investors in Cloud Infrastructure (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in Web3/Crypto (Seed), Investors in Web3/Crypto (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health IT (Seed)
Photo of Marcus Pratini de Moraes, Managing Partner at Yaya Capital
Marcus Pratini de Moraes
Yaya Capital·Managing Partner
Sweet spot: $2.5M
Range: $100K - $5.0M
Investors in Brazil
Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in BioTech (Series B), Investors in Diagnostics (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Cloud Infrastructure (Series B), Investors in Medical Devices (Seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Web3/Blockchain (Series B), Investors in Cloud Infrastructure (Seed), Investors in Cloud Infrastructure (Series A), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series A), Investors in Web3/Crypto (Series B), Investors in BioTech (Seed), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series A), Investors in Web3/Crypto (Series A), Investors in Health IT (Series A), Investors in Diagnostics (Series B), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Web3/Crypto (Seed), Investors in Web3/Blockchain (Series A), Investors in Web3/Blockchain (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Medical Devices (Series B), Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in Medical Devices (Series A), Investors in Web3/Blockchain (Series B), Investors in BioTech (Series B), Investors in Cloud Infrastructure (Series B), Investors in LatAm (Latin America) (Other Lists), Investors in Digital Health (Series B), Investors in Web3/Crypto (Series B), Investors in Health IT (Series B), Investors in Consumer Health (Series A), Investors in Health & Hospital Services (Series B), Investors in Web3/Blockchain (Seed), Investors in Web3/Blockchain (Series A), Investors in Cloud Infrastructure (Seed), Investors in Cloud Infrastructure (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in Web3/Crypto (Seed), Investors in Web3/Crypto (Series A), Investors in Digital Health (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health IT (Seed)
Photo of Carlos de Barros, Partner at DNA Capital
Carlos de Barros
DNA Capital·Partner
Sweet spot: $2.5M
Range: $100K - $5.0M
Investors in Sao Paulo (Brazil)
Investors in Medical Devices (Series B), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series B), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Consumer Health (Seed), Investors in Consumer Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed)
Photo of Adam Alves, Partner at DNA Capital
Adam Alves
DNA Capital·Partner
Sweet spot: $2.5M
Range: $100K - $5.0M
Investors in Sao Paulo (Brazil)
Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series B), Investors in Consumer Health (Seed), Investors in Consumer Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed)
Photo of Pedro Bueno, Partner at DNA Capital
Pedro Bueno
DNA Capital·Partner
Sweet spot: $2.5M
Range: $100K - $5.0M
Investors in Sao Paulo (Brazil)
Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Pre-seed), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Digital Health (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Pre-seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Pre-seed), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Pre-seed), Investors in Health IT (Pre-seed), Investors in Medical Devices (Series A), Investors in BioTech (Pre-seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed)
Photo of Felipe Mora Sarria, Partner at Impulsum Ventures
Felipe Mora Sarria
Sweet spot: $500K
Range: $500K - $500K
Investors in Medellin (Colombia), Investors in Santa Monica (CA), Investors in Barcelona (Spain)
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series B), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Series B), Investors in Health IT (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in Consumer Health (Series A), Investors in Pharmaceuticals (Seed), Investors in Consumer Internet (Series B), Investors in Medical Devices (Seed), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Consumer Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Health IT (Series A), Investors in Digital Health (Seed), Investors in FinTech (Series B), Investors in Consumer Internet (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Consumer Internet (Seed), Investors in Consumer Internet (Series B), Investors in Consumer Health (Series A), Investors in Digital Health (Series A), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in FinTech (Series B), Investors in FinTech (Seed), Investors in FinTech (Series A), Investors in Health IT (Seed), Investors in Health IT (Series A), Investors in Consumer Internet (Series A), Investors in FinTech (Series A), Investors in Consumer Internet (Seed), Investors in FinTech (Seed), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Seed), Investors in Consumer Health (Series A), Investors in Consumer Internet (Series B), Investors in Digital Health (Series A), Investors in FinTech (Series B), Investors in Digital Health (Seed), Investors in Health IT (Series A), Investors in Consumer Internet (Series A), Investors in Health IT (Seed), Investors in FinTech (Series A), Investors in Consumer Internet (Seed), Investors in FinTech (Seed)
Photo of Carlos Esteban Villa, Partner at Impulsum Ventures
Carlos Esteban Villa
Sweet spot: $500K
Range: $500K - $500K
Investors in Santa Monica (CA), Investors in Medellin (Colombia), Investors in Barcelona (Spain)
Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Series B), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series B), Investors in Health IT (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Series B), Investors in Consumer Health (Series B), Investors in Health & Hospital Services (Seed), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series B), Investors in Consumer Health (Series A), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Consumer Internet (Series B), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Seed), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Consumer Health (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series B), Investors in FinTech (Series B), Investors in Consumer Internet (Series A), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Consumer Internet (Seed), Investors in Consumer Internet (Series B), Investors in Consumer Health (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Consumer Health (Seed), Investors in Digital Health (Seed), Investors in FinTech (Series B), Investors in FinTech (Seed), Investors in FinTech (Series A), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Consumer Internet (Series A), Investors in FinTech (Series A), Investors in Consumer Internet (Seed), Investors in FinTech (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in Consumer Health (Seed), Investors in Consumer Health (Series A), Investors in Health & Hospital Services (Series B), Investors in Consumer Internet (Series B), Investors in Digital Health (Series A), Investors in FinTech (Series B), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Consumer Internet (Series A), Investors in Health IT (Seed), Investors in FinTech (Series A), Investors in Consumer Internet (Seed), Investors in FinTech (Seed)
Photo of Mario Sergio Ribeiro, Partner at DNA Capital
Mario Sergio Ribeiro
DNA Capital·Partner
Sweet spot: $2.5M
Range: $100K - $5.0M
Investors in Sao Paulo (Brazil)
Investors in Medical Devices (Series A), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Seed), Investors in Consumer Health (Series A), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed)
Get new data & insights delivered to your inbox
Firms investing in this space